Drug
6R-BH4
6R-BH4 is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)
Phase Distribution
Ph phase_2
3
100%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
3(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Terminated(1)
Other(1)
Detailed Status
Terminated1
unknown1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (100.0%)
Trials by Status
terminated133%
unknown133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_2
Neurovascular Transduction During Exercise in Chronic Kidney Disease
NCT02947750
terminatedphase_2
Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial Dysfunction
NCT00802893
unknownphase_2
Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)
NCT00423280
Clinical Trials (3)
Showing 3 of 3 trials
NCT02947750Phase 2
Neurovascular Transduction During Exercise in Chronic Kidney Disease
NCT00802893Phase 2
Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial Dysfunction
NCT00423280Phase 2
Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3